Drug information for COMPLERA

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
TABLET; ORAL	200MG;25MG;300MG	Prescription	(Reference Drug)	EMTRICITABINE; RILPIVIRINE; TENOFOVIR DISOPROXIL FUMARATE	emtricitabine	GILEAD SCIENCES INC	202123 2011-08-12 Letter 2011-08-11 Label

Drug Adverse Effects information for COMPLERA

Role code	Indications	Reaction	# Reports
PS	ANTIFUNGAL PROPHYLAXIS	CARDIAC FAILURE CONGESTIVE	1
PS	ANTIFUNGAL PROPHYLAXIS	DIALYSIS	1
PS	ANTIFUNGAL PROPHYLAXIS	SEPSIS	1
PS	ANTIFUNGAL PROPHYLAXIS	SUPRAVENTRICULAR TACHYCARDIA	1
PS	HIV INFECTION	CARDIAC FAILURE CONGESTIVE	1
PS	HIV INFECTION	DIALYSIS	1
PS	HIV INFECTION	FATIGUE	1
PS	HIV INFECTION	MYALGIA	1
PS	HIV INFECTION	NAUSEA	1
PS	HIV INFECTION	NIGHT SWEATS	1
PS	HIV INFECTION	POLYURIA	1
PS	HIV INFECTION	SEPSIS	1
PS	HIV INFECTION	SUPRAVENTRICULAR TACHYCARDIA	1
PS	HIV INFECTION	URINARY TRACT INFECTION	1
PS	HIV INFECTION	VOMITING	1
PS	HIV INFECTION	WEIGHT DECREASED	1
PS	PROPHYLAXIS	FATIGUE	1
PS	PROPHYLAXIS	MYALGIA	1
PS	PROPHYLAXIS	NAUSEA	1
PS	PROPHYLAXIS	NIGHT SWEATS	1
PS	PROPHYLAXIS	POLYURIA	1
PS	PROPHYLAXIS	URINARY TRACT INFECTION	1
PS	PROPHYLAXIS	VOMITING	1
PS	PROPHYLAXIS	WEIGHT DECREASED	1

Ads by Google